Trace Element Deficiency Clinical Trial
Official title:
Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers
The aim of the study is to determine the total concentration of selected trace elements (Cu, Zn, Fe), the proportion of free Cu and Cu bound to ceruloplasmin and the isotopic ratio of Cu65/Cu63 in blood serum samples from healthy volunteers and cancer patients using inductively coupled plasma mass spectrometry-based methods. The results will be statistically evaluated and the potential applications of the analytical methods used in cancer diagnosis and therapy will be assessed.
Status | Recruiting |
Enrollment | 20 |
Est. completion date | January 1, 2026 |
Est. primary completion date | January 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - aged =18 years - cytologically or histologically verified biliary tract cancer - no prior systemic therapy and no radiation therapy for advanced, inoperable or metastatic disease - WHO performance status 0 - 2 (ECOG criteria) - imaging diagnosis (CT of thoracic and abdominal organs) performed within 4 weeks prior to the first administration of systemic therapy - disease measurable by RECIST or ECOG criteria - signed Consent to Participate in Clinical Research form Exclusion Criteria: - prior systemic treatment and radiation therapy for inoperable, metastatic disease - WHO performance status > 2 (ECOG criteria) - contraindications to immunotherapy (known immunodeficiency or active immunosuppressive therapy or active autoimmune disease requiring treatment) - other malignancies, except cured basal cell or squamous cell carcinoma of the skin, in situ carcinoma of the cervix or other cured solid tumours without recurrence = 3 years after treatment. |
Country | Name | City | State |
---|---|---|---|
Slovenia | Institute of Oncology Ljubljana | Ljubljana |
Lead Sponsor | Collaborator |
---|---|
Institute of Oncology Ljubljana |
Slovenia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum copper (Cu) as a predictive biomarker of the response to systemic treatment of biliary tract cancer patients | The concentration of copper (Cu) in blood serum samples from healthy volunteers and biliary cancer patients will be measured to identify the differences in levels and the ratio between both groups, and to identify the serum Cu levels as a predictive biomarker of response to systemic therapy biliary tract cancer patients in the correlation with radiological CT evaluation. | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02126293 -
Correction of Zinc Deficiency in Children With Chronic Kidney Disease and Kidney Transplant
|
Phase 3 | |
Completed |
NCT03204669 -
Trace Element Repletion Following Severe Burn Injury
|
N/A | |
Completed |
NCT04587076 -
Evaluation of Protein Intake and Micronutrient Supplementation After Bariatric Surgery
|
||
Completed |
NCT04662242 -
The Prognostic Impact of Selenium On Critical Surgical Patients
|
Phase 4 |